Imaging Oxidative Metabolism and Neurotransmitter Synthesis in the Human Brain

NCT03849963 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 28

Last updated 2026-03-12

No results posted yet for this study

Summary

Investigators propose to develop hyperpolarized \[13C\]-labeled pyruvate as potential imaging probes to assess two essential in vivo processes in cerebral metabolism: oxidative metabolism and synthesis of a neurotransmitter in this observational study.

Conditions

  • Brain Metabolism

Sponsors & Collaborators

  • University of Texas Southwestern Medical Center

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2030-07-30
Primary Completion
2030-12-31
Completion
2030-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03849963 on ClinicalTrials.gov